Merger Impact Aceragen, formed through the merger of Idera Pharmaceuticals and Aceragen, focuses on rare disease treatments, presenting a sales opportunity in the niche market of rare/orphan diseases.
Recent Acquisitions Aceragen's strategic acquisitions of companies like Arrevus and Enzyvant have expanded its portfolio of investigational therapies, offering sales openings in new therapeutic areas and patient populations.
Highly Targeted Audience With a tech stack emphasizing security and user experience, Aceragen's digital presence appeals to healthcare professionals and patients, creating sales prospects through online engagement and education.
Key Personnel Changes The departure of key executives like Dr. Kraus and Bryant Lim may indicate organizational changes or new directions, prompting opportunities for sales outreach to understand evolving business strategies.
Strategic Funding Position Despite relatively lower revenue, Aceragen's $21M funding signals investor confidence and potential for rapid growth, presenting an opportunity for sales collaboration in scaling commercial operations.
3.4K
$1B
201
55$10M$50M
90$10M$50M
5K$100M$1BIdera Pharmaceuticals uses 8 technology products and services including W3 Total Cache, Sucuri, jQuery CDN, and more. Explore Idera Pharmaceuticals's tech stack below.
| Idera Pharmaceuticals Email Formats | Percentage |
| FLast@iderapharma.com | 82% |
| FirstLast@iderapharma.com | 6% |
| First_Last@iderapharma.com | 2% |
| Last_First@iderapharma.com | 2% |
| F.Last@iderapharma.com | 2% |
| Last@iderapharma.com | 1% |
| FirLast@iderapharma.com | 1% |
| FirstL@iderapharma.com | 1% |
| FirstMiddleLast@iderapharma.com | 1% |
| LastF@iderapharma.com | 1% |
| First_L@iderapharma.com | 1% |
| FLast@aceragen.com | 100% |
Biotechnology ResearchNorth Carolina, United States11-50 Employees
Idera Pharmaceuticals merged with Aceragen, Inc., a rare disease biopharmaceutical company, in September 2022. The company name was changed to Aceragen in early 2023.
Company Overview
Media & News
Funding & FinancialsIdera Pharmaceuticals has raised a total of $21M of funding over 4 rounds. Their latest funding round was raised on Apr 07, 2020 in the amount of $21M.
Idera Pharmaceuticals's revenue is in the range of $10M
Funding & FinancialsIdera Pharmaceuticals has raised a total of $21M of funding over 4 rounds. Their latest funding round was raised on Apr 07, 2020 in the amount of $21M.
Idera Pharmaceuticals's revenue is in the range of $10M
1-888-653-2347 
support@leadiq.com